TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News: EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) announced that it will sponsor a symposium at the European Hematology Association’s (EHA) 13th Congress taking place June 12 to 15, 2008 in Copenhagen, Denmark. The symposium, entitled “Recent advances in induction and post remission in Acute Myeloid Leukemia (AML),” will be held on June 12, 2008 from 10:00 a.m. – 12:45 p.m. local time at the Bella Center, Center Boulevard 5. The Symposium is being co-Chaired by leading AML experts, Dr. Alan Burnett from Cardiff, Wales and Dr. Jacob M. Rowe from Haifa, Israel.
